Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hip Fractures | 5 | 2020 | 76 | 2.190 |
Why?
|
| Renal Dialysis | 5 | 2020 | 945 | 1.150 |
Why?
|
| Kidney Failure, Chronic | 5 | 2021 | 960 | 1.020 |
Why?
|
| Acute Kidney Injury | 4 | 2021 | 739 | 0.770 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 135 | 0.740 |
Why?
|
| Metoprolol | 1 | 2018 | 28 | 0.660 |
Why?
|
| Kidney Transplantation | 3 | 2021 | 755 | 0.610 |
Why?
|
| Intensive Care Units | 1 | 2021 | 717 | 0.580 |
Why?
|
| Nephritis, Interstitial | 3 | 2022 | 76 | 0.500 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 598 | 0.410 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 1371 | 0.370 |
Why?
|
| Depression | 1 | 2019 | 1715 | 0.350 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 849 | 0.340 |
Why?
|
| Risk Assessment | 3 | 2019 | 6869 | 0.320 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2022 | 787 | 0.300 |
Why?
|
| Proton Pump Inhibitors | 2 | 2018 | 249 | 0.250 |
Why?
|
| Agricultural Workers' Diseases | 2 | 2020 | 20 | 0.210 |
Why?
|
| United States | 6 | 2021 | 15433 | 0.190 |
Why?
|
| Nickel | 1 | 2020 | 44 | 0.190 |
Why?
|
| Trace Elements | 1 | 2020 | 33 | 0.190 |
Why?
|
| Incidence | 3 | 2019 | 5673 | 0.180 |
Why?
|
| Hospitals, Veterans | 1 | 2021 | 397 | 0.170 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 321 | 0.170 |
Why?
|
| Nicaragua | 4 | 2020 | 30 | 0.170 |
Why?
|
| Waiting Lists | 1 | 2021 | 263 | 0.170 |
Why?
|
| Histamine H2 Antagonists | 1 | 2018 | 50 | 0.160 |
Why?
|
| Undocumented Immigrants | 1 | 2018 | 17 | 0.160 |
Why?
|
| Tissue and Organ Procurement | 1 | 2021 | 233 | 0.160 |
Why?
|
| Health Policy | 1 | 2021 | 291 | 0.160 |
Why?
|
| Causality | 1 | 2017 | 178 | 0.150 |
Why?
|
| Risk Factors | 6 | 2019 | 17523 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2021 | 451 | 0.140 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2018 | 323 | 0.140 |
Why?
|
| Case-Control Studies | 3 | 2020 | 6100 | 0.130 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 761 | 0.130 |
Why?
|
| Protein S | 1 | 2015 | 11 | 0.130 |
Why?
|
| Logistic Models | 2 | 2020 | 3441 | 0.130 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 198 | 0.130 |
Why?
|
| Male | 11 | 2022 | 123000 | 0.130 |
Why?
|
| Female | 10 | 2022 | 141928 | 0.110 |
Why?
|
| Middle Aged | 8 | 2020 | 86204 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 650 | 0.100 |
Why?
|
| Humans | 14 | 2021 | 261506 | 0.100 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2015 | 661 | 0.100 |
Why?
|
| Comorbidity | 1 | 2017 | 2352 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1148 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 29902 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2019 | 37905 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 2146 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 14889 | 0.080 |
Why?
|
| Aged | 4 | 2020 | 70117 | 0.070 |
Why?
|
| Prognosis | 3 | 2019 | 21713 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 2 | 2020 | 602 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 2488 | 0.070 |
Why?
|
| Adult | 6 | 2020 | 77950 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 4053 | 0.060 |
Why?
|
| Paraquat | 1 | 2022 | 19 | 0.060 |
Why?
|
| Agrochemicals | 1 | 2022 | 16 | 0.060 |
Why?
|
| Cations | 1 | 2022 | 62 | 0.050 |
Why?
|
| Farmers | 1 | 2020 | 5 | 0.050 |
Why?
|
| Endemic Diseases | 1 | 2020 | 67 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 4314 | 0.050 |
Why?
|
| Nails | 1 | 2020 | 36 | 0.050 |
Why?
|
| Health Care Rationing | 1 | 2021 | 94 | 0.050 |
Why?
|
| Young Adult | 4 | 2020 | 21445 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 649 | 0.040 |
Why?
|
| Occupational Exposure | 1 | 2020 | 244 | 0.040 |
Why?
|
| Creatinine | 1 | 2020 | 531 | 0.040 |
Why?
|
| Atrophy | 1 | 2017 | 261 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 600 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 5047 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2017 | 298 | 0.040 |
Why?
|
| Inflammation | 2 | 2017 | 2522 | 0.030 |
Why?
|
| Edema | 1 | 2017 | 267 | 0.030 |
Why?
|
| Rural Population | 1 | 2017 | 281 | 0.030 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2015 | 23 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 1062 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 793 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2018 | 12873 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1559 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 2316 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 6942 | 0.020 |
Why?
|
| Monocytes | 1 | 2015 | 788 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 3443 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 2218 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 4298 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 4892 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 6682 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12221 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 12926 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 34495 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 59536 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 31252 | 0.010 |
Why?
|